Skip to main content

Table 3 Associations between risk factors, probing site locations, treatment types, the presence of periodontopathogens and site healing

From: Influence of adjunctive azithromycin on microbiological and clinical outcomes in periodontitis patients: 6-month results of randomized controlled clinical trial

  OR (95% CI) p
Gender (male) 1.31 (0.45–3.84) 0.625
Age 1 (0.94–1.05) 0.893
Smoking 0.39 (0.13–1.20) 0.099
Test group 1.20 (0.44–3.27) 0.719
Molars 0.51 (0.35–0.72) < 0.001*
Interdental site 0.96 (0.65–1.41) 0.826
Aggregatibacter actinomycetemcomitans 1.68 (0.61–4.63) 0.318
Porphyromonas gingivalis 0.49 (0.17–1.41) 0.184
Prevotella intermedia 0.60 (0.09–4.16) 0.602
Tannerella forsythia 0.80 (0.20–3.15) 0.755
  1. OR odds ratio, CI confidence interval – *, statistically significant change